Linden Thomas Advisory Services’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$332K	Sell	1,326 -3,954	-75%	-$984K	0.03%	425
2025 Q4	$1.45M	Buy	5,280 +104	+2%	+$28.4K	0.15%	214
2025 Q3	$1.36M	Buy	5,176 +104	+2%	+$25.3K	0.14%	234
2025 Q2	$1.11M	Buy	5,072 +140	+3%	+$29.9K	0.12%	260
2025 Q1	$1.1M	Buy	4,932 +293	+6%	+$80.8K	0.14%	259
2024 Q4	$1.52M	Buy	4,639 +351	+8%	+$110K	0.19%	190
2024 Q3	$1.29M	Buy	4,288 +233	+6%	+$71.4K	0.18%	229
2024 Q2	$1.34M	Buy	4,055 +1,322	+48%	+$467K	0.21%	209
2024 Q1	$1.08M	Buy	2,733 +235	+9%	+$86.9K	0.17%	245
2023 Q4	$880K	Buy	2,498 +261	+12%	+$92.4K	0.16%	256
2023 Q3	$839K	Buy	2,237 +99	+5%	+$38.3K	0.19%	231
2023 Q2	$818K	Buy	2,138 +171	+9%	+$61.1K	0.18%	229
2023 Q1	$682K	Sell	1,967 -18	-0.9%	-$5.26K	0.17%	239
2022 Q4	$467K	Buy	+1,985	New	+$470K	0.13%	254